Ignite Creation Date:
2025-12-24 @ 4:45 PM
Ignite Modification Date:
2025-12-28 @ 3:29 AM
Study NCT ID:
NCT05004350
Status:
COMPLETED
Last Update Posted:
2025-04-15
First Post:
2021-04-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer.
Sponsor:
Pierre Fabre Medicament
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-07
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-30
First Submit QC Date:
None
Study First Post Date:
2021-08-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-10
Last Update Post Date:
2025-04-15
Last Update Post Date Type:
ACTUAL